Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Induced Pluripotent Stem Cells

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...

Induced Pluripotent Stem Cells

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...

Induced Pluripotent Stem Cells

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

EPS and iPS Cells in Disease Research

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...

Stem Cell Culture

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Oral Health, Inflammation, and Cardiometabolic Factors in the VA Million Veteran Program.

JDR clinical and translational research·2024

Same author

Peer Review Certifies Quality and Innovation in Clinical Pharmacology & Therapeutics.

Clinical pharmacology and therapeutics·2017

Same author

Affairs of the Heart: Innovation in Cardiovascular Research and Development.

Clinical pharmacology and therapeutics·2017

Same author

Clinical Pharmacology & Therapeutics: Past, Present, and Future.

Clinical pharmacology and therapeutics·2017

Same author

Managing Innovation to Maximize Value Along the Discovery-Translation-Application Continuum.

Clinical pharmacology and therapeutics·2016

Same author

Pharmacological Modulation of Calcium Homeostasis in Familial Dilated Cardiomyopathy: An In Vitro Analysis From an RBM20 Patient-Derived iPSC Model.

Clinical and translational science·2016

Search research articles

Related Experiment Video

Updated: Jun 2, 2026

Scalable 96-well Plate Based iPSC Culture and Production Using a Robotic Liquid Handling System

Scalable 96-well Plate Based iPSC Culture and Production Using a Robotic Liquid Handling System

Published on: May 14, 2015

Induced pluripotent stem cells: an emerging theranostics platform.

T J Nelson¹, A Terzic

¹Marriott Heart Disease Research Program, Division of Cardiovascular Diseases, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA. nelson.timothy@mayo.edu

Clinical Pharmacology and Therapeutics

|April 23, 2011

Summary

This summary is machine-generated.

Induced pluripotent stem (iPS) cells offer a powerful tool for creating personalized tissues. Understanding their regenerative dynamics can lead to advanced diagnostics and therapies.

More Related Videos

Generation of Induced Pluripotent Stem Cell-Derived iTenocytes via Combined Scleraxis Overexpression and 2D Uniaxial Tension

Generation of Induced Pluripotent Stem Cell-Derived iTenocytes via Combined Scleraxis Overexpression and 2D Uniaxial Tension

Published on: March 1, 2024

Generation of Induced Pluripotent Stem Cells from Human Melanoma Tumor-infiltrating Lymphocytes

Generation of Induced Pluripotent Stem Cells from Human Melanoma Tumor-infiltrating Lymphocytes

Published on: November 11, 2016

Related Experiment Videos

Last Updated: Jun 2, 2026

Scalable 96-well Plate Based iPSC Culture and Production Using a Robotic Liquid Handling System

Scalable 96-well Plate Based iPSC Culture and Production Using a Robotic Liquid Handling System

Published on: May 14, 2015

Generation of Induced Pluripotent Stem Cell-Derived iTenocytes via Combined Scleraxis Overexpression and 2D Uniaxial Tension

Generation of Induced Pluripotent Stem Cell-Derived iTenocytes via Combined Scleraxis Overexpression and 2D Uniaxial Tension

Published on: March 1, 2024

Generation of Induced Pluripotent Stem Cells from Human Melanoma Tumor-infiltrating Lymphocytes

Generation of Induced Pluripotent Stem Cells from Human Melanoma Tumor-infiltrating Lymphocytes

Published on: November 11, 2016

Area of Science:

Biomedical Science
Stem Cell Biology
Regenerative Medicine

Background:

Nuclear reprogramming generates induced pluripotent stem (iPS) cells with unlimited differentiation potential.
iPS cells represent a key tool for developing scalable, personalized cell-based therapies.
Regenerative theranostics offers a novel platform for studying disease mechanisms in cellular contexts.

Purpose of the Study:

To explore the potential of iPS cells in regenerative medicine.
To investigate the molecular dynamics governing stem cell regenerative capacity.
To enable patient-specific diagnostic and therapeutic applications.

Main Methods:

Utilizing nuclear reprogramming techniques to generate iPS cells.
Analyzing molecular dynamics of stem cell function.
Applying regenerative theranostics principles.

Main Results:

iPS cells possess the potential for genetically identical tissue reconstruction.
Understanding molecular dynamics is crucial for stem cell regulation.
Regenerative theranostics can elucidate disease etiology.

Conclusions:

iPS cell technology provides a foundation for advanced regenerative medicine.
Further research into molecular dynamics will unlock personalized diagnostics and therapeutics.
This approach holds promise for next-generation patient-specific treatments.